New Issue: Orbital Catastrophe Ahead? Read Now

LSD's Long, Strange Trip Explained

When LSD binds to serotonin receptors, it pulls a "lid" closed behind it, locking it in place for hours, and explaining its long-lasting effects. Christopher Intagliata reports. 

Illustration of a Bohr atom model spinning around the words Science Quickly with various science and medicine related icons around the text

Join Our Community of Science Lovers!

LSD is one of the most potent hallucinogenic drugs—active at just around 100 micrograms…a miniscule amount. That fact has fascinated pharmacologists for decades. Namely, how can it have such long-lasting effects…12 hours or more…at such tiny doses? 

To find out, researchers legally obtained LSD. And built copies of the receptors it binds to in the brain—serotonin receptors. They mixed the LSD and the receptors together, and crystallized the result. They then imaged the structure, using x-ray crystallography.

And they found that when LSD linked up with the serotonin receptor, a sort of "lid" formed over it. Almost like the drug went in, then pulled the door shut behind it. "You could think of the top part of LSD as a hand, holding onto the latch and pulling it down." Bryan Roth, a pharmacologist at University of North Carolina in Chapel Hill involved in the research. 


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


"This explains why LSD is so potent, why such a small amount of it is active, and secondly why it lasts for such a long period of time. Because basically once it gets in there it takes hours to come off the receptor." The study is in the journal Cell. [Daniel Wacker et al., Crystal Structure of an LSD-Bound Human Serotonin Receptor]

The result may also explain why microdosing—taking even smaller amounts of LSD, at sub-psychedelic levels—might work as a mood enhancer, as some users have reported. "It's clear from the data we have that these small doses can engage these receptors, and of course we know that the receptors that LSD interacts with, they're the same receptors that are thought to be involved in antidepressant drug action." 

Roth does not advocate trying it out. But he says the discovery of the "lid" might someday lead to the development of novel antidepressants—ones with long-lasting effects, at just the tiniest of doses.

—Christopher Intagliata

[The above text is a transcript of this podcast.]

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe